Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19208234 | CHROMOPHORIC COMPOUNDS AND UV-ABSORBING COMPOSITIONS | May 2025 | August 2025 | Allow | 3 | 0 | 0 | No | No |
| 19183794 | NEW TOPICAL FORMULATIONS OF RUXOLITINIB WITH AN ORGANIC AMINE PH ADJUSTING AGENT FOR TREATMENT OF SKIN DISEASES | April 2025 | October 2025 | Allow | 6 | 1 | 0 | No | No |
| 18947765 | THERAPEUTIC PUTTIES CONTAINING ADDITIVES INCLUDING PROCESSED HUMAN BLOOD PLASMA | November 2024 | March 2026 | Allow | 16 | 1 | 0 | No | No |
| 18940508 | METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS | November 2024 | January 2026 | Allow | 14 | 1 | 0 | No | No |
| 18928808 | TOPICAL PHARMACEUTICAL COMPOSITION CONTAINING PHOSPHOLIPIDS | October 2024 | October 2025 | Allow | 12 | 0 | 0 | No | No |
| 18920828 | MEDICAL DEVICES CONTAINING COMPOSITIONS OF POLY(BUTYLENE SUCCINATE) AND COPOLYMERS THEREOF | October 2024 | October 2025 | Allow | 12 | 0 | 0 | No | No |
| 18830292 | HYDROPHOBIC ORAL CARE COMPOSITIONS WITH HYDROPHOBIC HERBAL EXTRACT | September 2024 | September 2025 | Allow | 12 | 2 | 0 | No | No |
| 18784316 | SUNSCREEN COMPOSITION AND METHODS OF PROTECTION FROM ULTRAVIOLET AND VISIBLE LIGHT | July 2024 | January 2026 | Allow | 18 | 1 | 0 | No | No |
| 18775688 | COMPOSITION & METHODS FOR REGULATING MELANOGENESIS | July 2024 | October 2024 | Allow | 3 | 0 | 0 | No | No |
| 18761235 | STRUCTURALLY DIVERSE, STABLE, AND RADIATION-PROTECTIVE PARTICLE MATRIX SUNSCREEN AND COSMETIC COMPOSITIONS AND RELATED METHODS | July 2024 | June 2025 | Allow | 12 | 1 | 0 | No | No |
| 18751924 | TRANSDERMAL SOLVENT SYSTEM AND METHODS OF USE | June 2024 | September 2025 | Abandon | 15 | 1 | 0 | No | No |
| 18630377 | PRESERVATIVE SYSTEMS | April 2024 | November 2025 | Allow | 19 | 1 | 0 | No | No |
| 18620289 | METHODS, COMPOSITIONS, AND DEVICES FOR DRUG / LIVE CELL MICROARRAYS | March 2024 | January 2026 | Allow | 22 | 0 | 0 | No | No |
| 18694772 | COMPOSITION FOR REMEDYING INGROWN (TOE)NAIL | March 2024 | February 2026 | Allow | 23 | 0 | 0 | No | No |
| 18444424 | SUNSCREEN FORMULATIONS AND METHODS OF MAKING AND USING THE SAME | February 2024 | April 2025 | Allow | 14 | 2 | 0 | Yes | No |
| 18438591 | EXTRUDABLE PHOTOCROSSLINKABLE HYDROGEL AND METHOD FOR ITS PREPARATION | February 2024 | September 2024 | Allow | 7 | 0 | 0 | No | No |
| 18415162 | 2-(BENZO[B]THIOPHEN-3-YL)-1-BUTYL-4,5-DIPHENYL-1H-IMIDAZOLE AS AN ANTI-INFLAMMATORY AND ANTI-MICROBIAL COMPOUND | January 2024 | April 2024 | Allow | 3 | 0 | 0 | Yes | No |
| 18415207 | 2-(BENZO[B]THIOPHEN-3-YL)-1-BUTYL-4,5-DIPHENYL-1H-IMIDAZOLE AS AN ANTI-INFLAMMATORY AND ANTI-MICROBIAL COMPOUND | January 2024 | April 2024 | Allow | 3 | 0 | 0 | No | No |
| 18445732 | Visible Antiseptic Solution (VAS) | January 2024 | October 2025 | Abandon | 22 | 1 | 0 | No | No |
| 18399796 | COSMETIC COMPOSITION DERIVED FROM NATURAL PRODUCTS FOR IMPROVING SKIN HEALTH | December 2023 | January 2025 | Allow | 13 | 1 | 0 | No | No |
| 18544975 | SPRAYABLE COMPOSITIONS CONTAINING OIL-IN-WATER EMULSIONS CONTAINING SUBMICRON HYDROPHOBIC AGENTS AND METHODS OF USE THEREOF | December 2023 | March 2025 | Allow | 15 | 1 | 0 | No | No |
| 18567421 | DICLOFENAC TOPICAL FORMULATION WITH A HIGH ABSORPTION RATE | December 2023 | January 2026 | Allow | 25 | 1 | 0 | No | No |
| 18516303 | COMPOSITION FOR SUNSCREEN COSMETICS | November 2023 | January 2025 | Abandon | 14 | 1 | 0 | No | No |
| 18508746 | Oral Care Compositions and Methods of Use | November 2023 | May 2025 | Allow | 18 | 2 | 0 | No | No |
| 18385861 | 12-BROMO-2,16-DIOXA-9,9,18,18-TETRAMETHYLPENTACYCLO[7.7.5.0 1, 21.0 3,8.0 10,15]HENICOSA3(8),10,12,14-TETRAENE-7,20-DIONE AS AN ANTIMICROBIAL COMPOUND | October 2023 | February 2024 | Allow | 4 | 1 | 0 | No | No |
| 18384203 | Enhanced Toothpaste And Kits | October 2023 | September 2025 | Allow | 23 | 1 | 0 | Yes | No |
| 18490960 | METAL OXIDE PARTICLE ESTER DISPERSIONS INCLUDING POLYESTERS HAVING A BROAD MOLECULAR WEIGHT DISTRIBUTION | October 2023 | October 2025 | Allow | 24 | 1 | 0 | No | No |
| 18488030 | STRUCTURALLY DIVERSE, STABLE, AND RADIATION-PROTECTIVE PARTICLE MATRIX SUNSCREEN AND COSMETIC COMPOSITIONS AND RELATED METHODS | October 2023 | March 2024 | Allow | 5 | 0 | 0 | No | No |
| 18485560 | LIPO-AMINO ACID ALKYL ESTERS AS SPF BOOSTERS | October 2023 | January 2025 | Abandon | 15 | 1 | 0 | No | No |
| 18484963 | METHODS AND COMPOSITIONS TO INCREASE HAIR GROWTH AND/OR PREVENT HAIR LOSS | October 2023 | April 2025 | Allow | 18 | 1 | 0 | No | No |
| 18474923 | DEVICE AND METHOD FOR PROVIDING CUSTOMIZED SKIN COLOR MATCHING SUNSCREEN | September 2023 | April 2025 | Allow | 18 | 1 | 0 | No | No |
| 18242465 | 2-(BENZO[B]THIOPHEN-3-YL)-1-BUTYL-4,5-DIPHENYL-1H-IMIDAZOLE AS AN ANTI-INFLAMMATORY AND ANTI-MICROBIAL COMPOUND | September 2023 | April 2024 | Allow | 7 | 2 | 1 | No | No |
| 18366067 | Oral Care Compositions and Methods | August 2023 | April 2025 | Allow | 20 | 2 | 0 | No | No |
| 18227489 | SUNSCREEN COMPOSITION COMPRISING VISIBLE LIGHT PROTECTING AGENTS AND METHODS OF USE | July 2023 | June 2025 | Allow | 23 | 1 | 0 | No | No |
| 18273684 | TOPICAL PHARMACEUTICAL COMPOSITION CONTAINING PHOSPHOLIPIDS | July 2023 | August 2024 | Allow | 13 | 1 | 1 | Yes | No |
| 18256328 | INCREASED SOLUBILIZATION OF BEMOTRIZINOL | June 2023 | January 2026 | Allow | 32 | 1 | 0 | No | No |
| 18256336 | INCREASED SOLUBILIZATION OF DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE | June 2023 | January 2026 | Allow | 32 | 1 | 0 | No | No |
| 18256149 | INCREASED SOLUBILIZATION OF ISCOTRIZINOL | June 2023 | January 2026 | Allow | 32 | 1 | 0 | No | No |
| 18255536 | POLYMER CARBON NITRIDE, SPECIFIC CRYSTAL FORM OF SAID POLYMER CARBON NITRIDE, AND ULTRAVIOLET RAY-BLOCKING USE THEREOF | June 2023 | January 2026 | Allow | 32 | 0 | 0 | No | No |
| 18198369 | COMPOSITION OF CHLORHEXIDINE | May 2023 | February 2024 | Allow | 9 | 3 | 0 | Yes | No |
| 18307373 | THERAPEUTIC PUTTIES CONTAINING ADDITIVES INCLUDING PROCESSED HUMAN BLOOD PLASMA | April 2023 | January 2025 | Allow | 21 | 1 | 0 | No | No |
| 18304685 | Compositions Containing Ibrutinib | April 2023 | February 2025 | Abandon | 21 | 3 | 0 | No | No |
| 18134830 | WATERPROOF MINERAL SUNSCREEN COMPOSITIONS | April 2023 | October 2025 | Allow | 30 | 0 | 0 | No | No |
| 18246804 | A PRODUCT FOR TREATING SKIN FUNGUS AND ITS MICRONIZED PREPARATION METHOD | March 2023 | August 2024 | Allow | 17 | 2 | 1 | No | No |
| 18107060 | NOVEL HIGHLY SUSTAINABLE COMPOSITIONS FOR MODULATION OF GENE EXPRESSION IN HUMAN SKIN, AND METHODS OF PRODUCTION THEREOF | February 2023 | October 2024 | Allow | 20 | 1 | 0 | No | No |
| 18151269 | FENOLDOPAM TOPICAL FORMULATIONS FOR TREATING SKIN DISORDERS | January 2023 | May 2025 | Abandon | 28 | 1 | 0 | No | No |
| 18091492 | METHODS FOR CONTINUOUS MANUFACTURE OF LIPOSOMAL DRUG PRODUCTS | December 2022 | December 2024 | Allow | 24 | 1 | 0 | No | No |
| 18091556 | ORAL FILM COMPOSITIONS AND DOSAGE FORMS HAVING PRECISE ACTIVE DISSOLUTION PROFILES | December 2022 | July 2023 | Allow | 7 | 2 | 0 | No | No |
| 18011607 | DISINFECTING, SKIN-TOLERABLE CARE AGENT FOR APPLICATION TO THE SKIN | December 2022 | November 2025 | Abandon | 35 | 1 | 0 | No | No |
| 18083840 | Personal Care Compositions | December 2022 | April 2025 | Allow | 28 | 1 | 0 | No | No |
| 18009483 | SOLID COSMETIC COMPOSITION FOR BLOCKING ULTRAVIOLET RADIATION HAVING WATER RESISTANCE AND CLEANSING PROPERTIES | December 2022 | February 2026 | Allow | 38 | 1 | 0 | Yes | No |
| 18077379 | SUNSCREEN COMPOSITION INCLUDING A FLUORESCENT AGENT EXCITABLE BY AN ULTRAVIOLET LAM | December 2022 | December 2025 | Abandon | 36 | 1 | 0 | No | No |
| 18070572 | SKIN CARE COMPOSITION | November 2022 | June 2025 | Allow | 31 | 0 | 0 | No | No |
| 18059726 | LIPIDATED IMMUNE RESPONSE MODIFIER COMPOUND COMPOSITIONS, FORMULATIONS, AND METHODS | November 2022 | September 2024 | Allow | 21 | 1 | 0 | No | No |
| 17925846 | A HIGH SPF SKIN CLEANSING COMPOSITION | November 2022 | September 2023 | Allow | 10 | 1 | 0 | No | No |
| 17989307 | ORAL FILM COMPOSITIONS AND DOSAGE FORMS HAVING PRECISE ACTIVE DISSOLUTION PROFILES | November 2022 | December 2024 | Allow | 25 | 1 | 0 | No | No |
| 17925489 | CATECHOL FUNCTIONAL ORGANOPOLYSILOXANE, METHOD FOR PRODUCING SAME, AND POWDER TREATMENT AGENT | November 2022 | December 2025 | Allow | 37 | 2 | 0 | No | No |
| 17925187 | FAST AUTOMATED APPROACH FOR THE DERIVATION OF ACELLULAR EXTRACELLULAR MATRIX SCAFFOLDS FROM TISSUES | November 2022 | September 2025 | Allow | 34 | 0 | 0 | No | No |
| 18054816 | TESTOSTERONE TRANSDERMAL SPRAY WITH FILM | November 2022 | September 2024 | Allow | 22 | 1 | 0 | No | No |
| 17984761 | PHOSPHATIDYLCHOLINE LIPID LIPOSOMES AS BOUNDARY LUBRICANTS IN AQUEOUS MEDIA | November 2022 | March 2025 | Allow | 28 | 1 | 0 | No | No |
| 17998063 | LIPOSOME FORMULATIONS FOR TREATMENT OF CANCERS AND DRUG RESISTANCE OF CANCERS | November 2022 | March 2026 | Allow | 40 | 1 | 1 | No | No |
| 17975892 | COSMETIC COMPOSITION | October 2022 | February 2024 | Allow | 15 | 1 | 1 | No | No |
| 17921356 | EXTERNAL NANO LINIMENT FOR GOUT AND PREPARATION METHOD THEREOF | October 2022 | October 2025 | Allow | 35 | 1 | 1 | Yes | No |
| 18045974 | COMPOSITION FOR PROMOTING HAIR GROWTH | October 2022 | December 2023 | Allow | 14 | 1 | 0 | No | No |
| 17962115 | METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS | October 2022 | August 2024 | Allow | 22 | 1 | 0 | No | No |
| 17917282 | LAMINARIN BASED FORMULATION FOR AGRICULTURAL APPLICATIONS | October 2022 | June 2025 | Allow | 33 | 1 | 0 | No | No |
| 17951734 | Oral Care Compositions and Methods of Use | September 2022 | December 2025 | Allow | 38 | 2 | 0 | No | No |
| 17951726 | SKIN CARE MASK AND METHOD OF MANUFACTURE | September 2022 | October 2023 | Allow | 13 | 2 | 0 | No | No |
| 17951988 | INORGANIC SUNSCREEN ACTIVE AGENTS IN COSMETIC COMPOSITIONS AND METHODS | September 2022 | October 2023 | Abandon | 12 | 1 | 0 | No | No |
| 17948790 | COMBINATIONS OF BETA-LACTAM COMPOUNDS AND PROBENECID AND USES THEREOF | September 2022 | August 2025 | Allow | 35 | 2 | 0 | No | No |
| 17902741 | COMPOSITION FOR SUNSCREEN COSMETICS | September 2022 | January 2023 | Allow | 4 | 1 | 0 | No | No |
| 17895911 | SUNSCREEN COMPOSITION AND METHODS OF PROTECTION FROM ULTRAVIOLET AND VISIBLE LIGHT | August 2022 | April 2024 | Allow | 20 | 1 | 0 | No | No |
| 17820548 | PERSONAL CARE COMPOSITION CONTAINING SPHERICAL SILICONE ELASTOMER FINE PARTICLES | August 2022 | September 2024 | Allow | 25 | 0 | 0 | No | No |
| 17888587 | Malodor Suppression in Brassica Amidoalkyl Containing Cosmetic Compositions | August 2022 | May 2024 | Allow | 21 | 2 | 0 | No | No |
| 17803532 | METHOD OF ENCOURAGING GROWTH AND REGROWTH OF HAIR IN HUMAN MALES TECHNICAL AREA | August 2022 | June 2023 | Allow | 10 | 0 | 0 | No | No |
| 17819350 | Binder For Use In Powdery Cosmetic Compositions | August 2022 | June 2023 | Allow | 11 | 0 | 0 | No | No |
| 17881411 | MASK | August 2022 | March 2024 | Abandon | 19 | 2 | 0 | No | No |
| 17876837 | HYBRID MINERAL AND ORGANIC DAILY SUNSCREEN THICK CREAM MOISTURIZER | July 2022 | January 2024 | Allow | 17 | 1 | 0 | No | No |
| 17796578 | SKIN BARRIER FUNCTION ENHANCER | July 2022 | October 2025 | Abandon | 39 | 1 | 0 | No | No |
| 17796580 | INFLAMMATION-SUPPRESSING AGENT | July 2022 | October 2025 | Allow | 38 | 1 | 0 | No | No |
| 17868419 | HAIR OIL | July 2022 | January 2024 | Allow | 18 | 1 | 0 | No | No |
| 17813237 | SUNSCREEN COMPOSITION CONTAINING VISIBLY TRANSPARENT BIOCOMPATIBLE ULTRAVIOLET BLOCKING POLYMER NANOPARTICLES | July 2022 | March 2024 | Allow | 20 | 0 | 0 | No | No |
| 17812254 | ARTIFICIAL BETA CELLS AND METHODS OF USE THEREOF | July 2022 | September 2024 | Allow | 26 | 0 | 0 | No | No |
| 17792577 | ANTI-POLLUTION COMPOSITE POWDER HAVING UV- AND FINE DUST-BLOCKING FUNCTION AND COSMETIC COMPOSITION COMPRISING SAME | July 2022 | January 2026 | Allow | 42 | 1 | 1 | No | No |
| 17811970 | PHARMACEUTICAL FORMULATION | July 2022 | December 2024 | Allow | 30 | 1 | 0 | No | No |
| 17811817 | Hoof treatment comprising Chlorine Dioxide | July 2022 | December 2023 | Abandon | 18 | 1 | 0 | No | No |
| 17860389 | TOPICAL COMPOSITIONS CONTAINING ROSE OIL AND CANNABIDIOL AND METHODS OF MAKING AND USING THE SAME | July 2022 | October 2024 | Allow | 27 | 1 | 0 | No | No |
| 17853005 | METHODS AND COMPOSITIONS FOR TREATMENT OF PULMONARY HYPERTENSION AND OTHER LUNG DISORDERS | June 2022 | November 2024 | Allow | 29 | 1 | 0 | No | No |
| 17850931 | Complexation of Curcumin with Calixarene Derivatives | June 2022 | June 2023 | Allow | 12 | 1 | 1 | No | No |
| 17848608 | Natural 1,2-Alkanediols, Compositions Having Natural 1,2-Alkanediols and Processes for Making the Same | June 2022 | October 2024 | Abandon | 28 | 1 | 0 | No | No |
| 17788565 | WATER-IN-OIL EMULSION COSMETIC PREPARATION FOR SKIN | June 2022 | June 2025 | Allow | 36 | 1 | 0 | No | No |
| 17847455 | Bacterial Cellulose-Polyurethane Composite Material, Preparation Method Therefor, and Application Thereof | June 2022 | June 2025 | Allow | 36 | 0 | 1 | No | No |
| 17845688 | METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS | June 2022 | August 2024 | Allow | 25 | 1 | 0 | No | No |
| 17844930 | COSMETIC COMPOSITION COMPRISING NATURAL EMULSIFIERS AND THIOPYRIDINONE COMPOUNDS | June 2022 | October 2024 | Allow | 27 | 1 | 1 | No | No |
| 17786439 | METHOD FOR THE COSMETIC TREATMENT OF KERATIN MATERIALS EMPLOYING A RARE EARTH METAL COMPOSITION AND AN ALKALINE COMPOSITION | June 2022 | September 2025 | Allow | 39 | 1 | 0 | No | No |
| 17785697 | SUNSCREEN COSMETIC | June 2022 | February 2026 | Allow | 44 | 2 | 0 | No | No |
| 17838523 | COMPOSITION AND METHOD FOR A TOPICAL TREATMENT FOR VENOM NEUTRALIZATION | June 2022 | September 2023 | Abandon | 15 | 1 | 0 | No | No |
| 17784181 | COMPOSITION COMPRISING AT LEAST 5% BY WEIGHT OF TITANIUM OXIDES, AN a-CYANODIPHENYLACRYLATE DERIVATIVE AND A 4-HYDROXYBENZYLIDENEMALONATE OR 4-HYDROXYCINNAMATE DERIVATIVE | June 2022 | June 2025 | Allow | 36 | 1 | 0 | No | No |
| 17831207 | Composition for a Skin and Hair Product | June 2022 | January 2023 | Allow | 7 | 0 | 0 | No | No |
| 17826315 | ORGANIC SUNSCREEN COMPOSITION AND PROCESS FOR PROTECTING SKIN FROM PHOTODAMAGE AND AGING | May 2022 | June 2025 | Allow | 37 | 2 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HOLLOMAN, NANNETTE.
With a 33.3% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 37.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner HOLLOMAN, NANNETTE works in Art Unit 1612 and has examined 821 patent applications in our dataset. With an allowance rate of 60.5%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 31 months.
Examiner HOLLOMAN, NANNETTE's allowance rate of 60.5% places them in the 21% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by HOLLOMAN, NANNETTE receive 1.84 office actions before reaching final disposition. This places the examiner in the 43% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by HOLLOMAN, NANNETTE is 31 months. This places the examiner in the 53% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.
Conducting an examiner interview provides a +18.9% benefit to allowance rate for applications examined by HOLLOMAN, NANNETTE. This interview benefit is in the 62% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 25.5% of applications are subsequently allowed. This success rate is in the 40% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 25.4% of cases where such amendments are filed. This entry rate is in the 35% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.
When applicants request a pre-appeal conference (PAC) with this examiner, 80.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 62% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 76.5% of appeals filed. This is in the 68% percentile among all examiners. Of these withdrawals, 51.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 58.2% are granted (fully or in part). This grant rate is in the 61% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 1.5% of allowed cases (in the 71% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).
Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.4% of allowed cases (in the 71% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.